0001437749-24-019721.txt : 20240610 0001437749-24-019721.hdr.sgml : 20240610 20240607174856 ACCESSION NUMBER: 0001437749-24-019721 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240605 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240610 DATE AS OF CHANGE: 20240607 FILER: COMPANY DATA: COMPANY CONFORMED NAME: cbdMD, Inc. CENTRAL INDEX KEY: 0001644903 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 473414576 STATE OF INCORPORATION: NC FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38299 FILM NUMBER: 241030889 BUSINESS ADDRESS: STREET 1: 8845 RED OAK BOULEVARD CITY: CHARLOTTE STATE: NC ZIP: 28217 BUSINESS PHONE: 704-445-3060 MAIL ADDRESS: STREET 1: 8845 RED OAK BOULEVARD CITY: CHARLOTTE STATE: NC ZIP: 28217 FORMER COMPANY: FORMER CONFORMED NAME: Level Brands, Inc. DATE OF NAME CHANGE: 20170202 FORMER COMPANY: FORMER CONFORMED NAME: LEVEL BEAUTY GROUP, INC. DATE OF NAME CHANGE: 20150611 8-K 1 ycbd20240606_8k.htm FORM 8-K ycbd20240606_8k.htm
false 0001644903 0001644903 2024-06-05 2024-06-05 0001644903 ycbd:CommonCustomMember 2024-06-05 2024-06-05 0001644903 ycbd:SeriesACumulativeConvertiblePreferredStock8CustomMember 2024-06-05 2024-06-05
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) June 5, 2024
 
logo.jpg
 
cbdMD, INC.
(Exact name of registrant as specified in its charter)
 
North Carolina
001-38299
47-3414576
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
 
2101 Westinghouse Blvd Suite A, Charlotte, NC 28273
(Address of principal executive offices)(Zip Code)
 
Registrant's telephone number, including area code: (704) 445-3060
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common
YCBD
NYSE American
8% Series A Cumulative Convertible Preferred Stock
YCBD PR A
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
  
 
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
ITEM 3.01 Notice Of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
 
On June 5, 2024, cbdMD, Inc. (the “Company”) received notification (the “Notice”) from the NYSE American LLC (the “NYSE American”) that the Company is no longer in compliance with NYSE American’s continued listing standards. Specifically, the letter states that the Company is not in compliance with the continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”). Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Company reported stockholders equity of $3.1 million as of March 31, 2024, and losses from continuing operations and/or net losses in three of its four most recent fiscal years ended September 30, 2023.
 
The Notice further provides that the Company must submit a plan of compliance (the “Plan”) by July 5, 2024 addressing how it intends to regain compliance with the continued listing standards by December 5, 2025. The Plan is required to include specific milestones, quarterly financial projections and details related to any strategic initiatives the Company plans to complete.
 
The Company has begun to prepare its Plan for submission to the NYSE American by the July 5, 2024 deadline. If the NYSE American accepts the Company’s Plan, the Company will be able to continue its listing during the Plan period and will be subject to continued periodic review by the NYSE American staff. If the Plan is not submitted, or not accepted, or is accepted but the Company is not in compliance with the continued listing standards by December 5, 2025 or if the Company does not make progress consistent with the Plan during the Plan period, the Company will be subject to delisting procedures as set forth in the NYSE American Company Guide.
 
The Company is committed to undertaking a transaction or transactions in the future to achieve compliance with the NYSE American’s requirements. However, there can be no assurance that the Company will be able to achieve compliance with the NYSE American’s continued listing standards within the required timeframe.
 
The Notice has no immediate impact on the listing of the Company’s shares of common stock (the “Common Stock”) or Series A Preferred Stock (the “Preferred Stock”), which will continue to be listed and traded on the NYSE American during this period, subject to the Company’s compliance with the other listing requirements of the NYSE American. The Common Stock and Preferred Stock will continue to trade under the symbol “YCBD” and “YCBD-PA”, respectively, but will have an added designation of “.BC” to indicate the status of the Common Stock and Preferred Stock as “below compliance”. The notice does not affect the Company’s ongoing business operations or its reporting requirements with the Securities and Exchange Commission.
 
If the Common Stock and Preferred Stock ultimately were to be delisted for any reason, it could negatively impact the Company by (i) reducing the liquidity and market price of the Company’s Common Stock and Preferred Stock; (ii) reducing the number of investors willing to hold or acquire the Common Stock and Preferred Stock, which could negatively impact the Company’s ability to raise equity financing; (iii) limiting the Company’s ability to use a registration statement to offer and sell freely tradable securities, thereby preventing the Company from accessing the public capital markets; and (iv) triggering an event of default under the Company’s outstanding Senior Secured Convertible Promissory Notes.
 
Item 8.01 Other Events.
 
On June 7, 2024, in accordance with the NYSE American’s procedures, the Company issued a press release discussing the matters disclosed in Item 3.01 above. A copy of the press release is included herewith as Exhibit 99.1, which is incorporated by reference into this Item 8.01.
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
Number
  
Exhibit
99.1
  
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
1
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
cbdMD, Inc.
     
Date: June 7, 2024
By:
/s/ T. Ronan Kennedy
   
T. Ronan Kennedy, Chief Executive Officer and Chief Financial Officer
 
2
EX-99.1 2 ex_684966.htm EXHIBIT 99.1 ex_684966.htm

Exhibit 99.1

 

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

 

Charlotte, North Carolina, June 7, 2024 - cbdMD, Inc. (NYSE American: YCBD and YCBD-PA) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs, today announced that it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) dated June 5, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards. Specifically, the letter states that the Company is not in compliance with the continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”). Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal year. The Company reported stockholders’ equity of $3.1 million as of March 31, 2024, and losses from continuing operations and/or net losses in three of its four most recent fiscal years ended September 30, 2023. The Notice further provides that the Company must submit a plan of compliance (the “Plan”) by July 5, 2024 addressing how it intends to regain compliance with the continued listing standards by December 5, 2025.

 

The Notice has no immediate impact on the listing of the Company’s shares of common stock (the “Common Stock”) or Series A Preferred Stock (the “Preferred Stock”), which will continue to be listed and traded on the NYSE American during the Plan period, subject to the Company’s compliance with the other listing requirements of the NYSE American. The Common Stock and Preferred Stock will continue to trade under the symbol “YCBD” and “YCBD-PA”, respectively, but will have an added designation of “BC” to indicate the status of the Common Stock and Preferred Stock as “below compliance”. The Notice does not affect the Company's ongoing business operations or its reporting requirements with the Securities and Exchange Commission.

 

The Company has begun to prepare its Plan for submission to the NYSE American by the July 5, 2024 deadline.  If the NYSE American accepts the Plan, the Company will be able to continue its listing during the Plan period and will be subject to continued periodic review by the NYSE American staff. If the Plan is not submitted, or not accepted, or is accepted but the Company is not in compliance with the continued listing standards by December 5, 2025 or if the Company does not make progress consistent with the Plan during the Plan period, the Company will be subject to delisting procedures as set forth in the NYSE American Company Guide.

 

The Company is focused on achieving positive net income and has already announced significant cost reductions that will be in place by August 2024.  The Company is committed to undertaking a transaction or transactions in the future to achieve compliance with the NYSE American’s requirements, including but not limited to seeking shareholder approval to convert the Preferred Stock and its accrued dividend, a liability totaling $2.7 million on March 31, 2024.  Under certain Preferred Stock conversion proposals, the accrued dividend would move to equity and increase the Company’s stockholder equity.  However, there can be no assurance that the Company will be able to achieve compliance with the NYSE American’s continued listing standards within the required timeframe.

 

About cbdMD

 

cbdMD, Inc. is one of the leading and most highly trusted and most recognized Cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products, including NSF Certified for Sport® products, as well as a wide array of Full Spectrum products. Our cbdMD brand currently includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids, and a growing collection of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products including tinctures and chews in varying strengths, and our ATRx Labs brand of natural functional mushroom support. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD oil and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, or ATRxLabs.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retailers nationwide that carry cbdMD's products.

 

Forward-Looking Statements

 

This communication contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including with regard to the Company ability to timely submit its Plan to the NYSE American, the acceptance of its Plan by the NYSE American and the Company's ability to regain compliance with the NYSE American's continued listing standards by December 5, 2025. These forward-looking statements are based on management's beliefs and assumptions and information currently available. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project” and similar expressions that do not relate solely to historical matters identify forward-looking statements. Investors should be cautious in relying on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking statements. These factors include, but are not limited to those described in our Form 10-K and other filings with the U.S. Securities and Exchange Commission. All information set forth in this press release is as of the date hereof. You should consider these factors in evaluating the forward-looking statements included in this press release and not place undue reliance on such statements. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by law.

 

1 THC-free is defined as below the level of detection using validated scientific analytical methods.

 

Contact Information:

 

cbdMD, Inc.

Ronan Kennedy, CEO & CFO

+1 (704) 445-3064

IR@cbdmd.com

 

 
 EX-101.SCH 3 ycbd-20240605.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 ycbd-20240605_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 ycbd-20240605_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key Class of Stock [Axis] Class of Stock [Domain] Common Custom [Member] SeriesACumulativeConvertiblePreferredStock8 Custom [Member] EX-101.PRE 6 ycbd-20240605_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 logo.jpg begin 644 logo.jpg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htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document And Entity Information
Jun. 05, 2024
Document Information [Line Items]  
Entity, Registrant Name cbdMD, INC.
Document, Type 8-K
Document, Period End Date Jun. 05, 2024
Entity, Incorporation, State or Country Code NC
Entity, File Number 001-38299
Entity, Tax Identification Number 47-3414576
Entity, Address, Address Line One 2101 Westinghouse Blvd Suite A
Entity, Address, City or Town Charlotte
Entity, Address, State or Province NC
Entity, Address, Postal Zip Code 28273
City Area Code 704
Local Phone Number 445-3060
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001644903
Common Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common
Trading Symbol YCBD
Security Exchange Name NYSE
SeriesACumulativeConvertiblePreferredStock8 Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security 8% Series A Cumulative Convertible Preferred Stock
Trading Symbol YCBD PR A
Security Exchange Name NYSE
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 3 22 1 false 2 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.ycbd.com/20240605/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports ycbd-20240605.xsd ycbd-20240605_def.xml ycbd-20240605_lab.xml ycbd-20240605_pre.xml ycbd20240606_8k.htm logo.jpg http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ycbd20240606_8k.htm": { "nsprefix": "ycbd", "nsuri": "http://www.ycbd.com/20240605", "dts": { "schema": { "local": [ "ycbd-20240605.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "ycbd-20240605_def.xml" ] }, "labelLink": { "local": [ "ycbd-20240605_lab.xml" ] }, "presentationLink": { "local": [ "ycbd-20240605_pre.xml" ] }, "inline": { "local": [ "ycbd20240606_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 30, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 25 }, "report": { "R1": { "role": "http://www.ycbd.com/20240605/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ycbd20240606_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ycbd20240606_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "ycbd_CommonCustomMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ycbd.com/20240605", "localname": "CommonCustomMember", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Common Custom [Member]" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "ycbd_SeriesACumulativeConvertiblePreferredStock8CustomMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ycbd.com/20240605", "localname": "SeriesACumulativeConvertiblePreferredStock8CustomMember", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "SeriesACumulativeConvertiblePreferredStock8 Custom [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.ycbd.com/20240605/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001437749-24-019721-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-019721-xbrl.zip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end XML 19 ycbd20240606_8k_htm.xml IDEA: XBRL DOCUMENT 0001644903 2024-06-05 2024-06-05 0001644903 ycbd:CommonCustomMember 2024-06-05 2024-06-05 0001644903 ycbd:SeriesACumulativeConvertiblePreferredStock8CustomMember 2024-06-05 2024-06-05 false 0001644903 8-K 2024-06-05 cbdMD, INC. NC 001-38299 47-3414576 2101 Westinghouse Blvd Suite A Charlotte NC 28273 704 445-3060 false false false false Common YCBD NYSE 8% Series A Cumulative Convertible Preferred Stock YCBD PR A NYSE false